Biosimilars, Compounding and Pharmacy Technician

Flu Vaccines Are a Go

Pharmacy Times

JULY 16, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Vaccines

Vaccines Insurance Coverage and Processing Pharmacy Technician Community Pharmacies

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Vaccines

Vaccines Pharmacy Technician Immunity Immunization

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

Pharmacy Times

JULY 25, 2025

Public transit cuts during COVID-19 compound social vulnerability in 22 US cities. 2022.103435 Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. MMWR Morb Mortal Wkly Rep. 2021;70:245-249. doi:10.15585/mmwr.mm7007a4.

Vaccines

Vaccines Pharmacy Technician Compounding Pharmacies Biosimilars

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

JUNE 24, 2025

Author(s): Alexandra Gerlach, Associate Editor , Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting.

Flu Vaccines Are a Go

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Trending Sources

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

The Changing Landscape of Pharmacy Accessibility

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Pharmacists Reimagine Myeloma Care With Insights from ASCO

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Carefully Monitor Direct Oral Anticoagulant Medications

Pharmacies Need Strategies to Improve Health Care Access

The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Collaborative Management of Severe Pericarditis: The Role of Pharmacists in Rilonacept Treatment

New Drugs, New Decisions: How Pharmacists Are Guiding the Future of Hematologic Care

Educate Patients About Safe Medication Disposal

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

Pharmacists Can Educate Patients About Sun Safety

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

Pharmacists Can Provide Travel Health Tips for Patients

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma

FDA Approves Dupilumb for Treatment of Bullous Pemphigoid

Hypertension: A Silent Killer Requiring Novel Therapies

Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback

Understanding Biologics and Biosimilars Amid an Evolving Treatment Landscape

Pharmacists Weigh Promise and Challenges of Finerenone for Patients With HFpEF

Correct Patient Misconceptions Around Biosimilars

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

Moving the Needle From Vaccine Hesitancy to Vaccine Acceptance

A Review of Oral Cephalosporins for Common Outpatient Infections

Once-Daily Alixorexton Improves Wakefulness at All Doses in Patients With Narcolepsy Type 1

FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Avatrombopag Receives FDA Approval for Treamtent of Pediatric Patients With Chronic Immune Thrompcytopenia

Shaping Pharmacy Research With Purpose and Public Impact

ADA 2025: Insights into Diabetes, Obesity, and Pharmacist's Role in Advancing Care

Stay Connected